Parliament on Thursday signed new legislation that updates the operation of the Hellenic Pasteur Institute (HEP), in a draft bill submitted on Wednesday by Alternate Research and Innovation Minister Kostas Fotakis.
According to the legislation, the members of HEP’s board of directors will be appointed by joint ministerial decision (JMC) of the ministries of education and health – the two ministries supervising the Institute. This will establish the institute as a research center in accordance with the recent legislation on research passed in 2016.
At the same time, the new contract will modernize the Institute’s operational framework, in line with modern scientific and medical developments to promote public health.
The new bill also modernizes the framework under which the Institute operates, based on contemporary scientific and medical developments to promote public health.
HEP’s primary mission is the prevention of infectious diseases. Its goals also include fighting against autoimmune, neurodegenerative, neuromuscular diseases, as well as various forms of cancer. Its contribution extends to the production of vaccines for rare diseases and is the direct recipient of government directives for the procurement, production, storage and disposal of vaccines.